Insider Trading & Executive Data
Start Free Trial
24 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Hydrofarm Holdings Group is a North American manufacturer and wholesale distributor of controlled-environment agriculture (CEA) and hydroponics equipment and supplies, selling grow lights, climate-control systems, grow media, nutrients and related products under ~35 proprietary brands and ~50 preferred brands. Consumables (about 75% of 2024 sales) drive recurring revenue while proprietary SKUs (~56% of 2024 revenue) typically deliver higher gross margins. The company has a mixed in‑house manufacturing and broad distribution footprint (multiple U.S. and Canadian DCs, one European DC) and is exposed to demand cycles in cannabis, commercial ag and consumer gardening. Recent years have seen declining sales, significant restructuring, inventory write‑downs, an asset sale and pressure on liquidity and covenants.
Given the company’s industrial/wholesale profile and recent operating stress, executive pay is likely shifting toward performance‑based metrics tied to margin recovery, adjusted EBITDA, cash flow generation and working‑capital improvements (inventory turns/reductions and receivable collection). The large share of recurring consumables and proprietary brand mix suggests incentives could include targets for proprietary-revenue mix, gross margin expansion and distributor inventory metrics (e.g., sell‑through or DMI performance). Because Hydrofarm has cut SG&A (notably compensation) and completed restructuring, short‑term cash bonuses may be constrained and equity‑linked incentives (RSUs/options tied to multi‑year operational milestones or TSR) and retention grants are more likely to be used to conserve cash while motivating turnaround execution. Loan covenants, reinvestment requirements tied to the 2024 asset sale and heightened impairment risk make compensation plans sensitive to covenant compliance and may include clawback or double‑trigger vesting features to limit windfalls if results later reverse.
Insider trading at Hydrofarm should be viewed through the lens of a cyclical, event‑driven business: material catalysts (restructuring announcements, inventory write‑downs, asset sales, covenant testing updates, or cannabis regulatory developments) can produce sharp share‑price moves and thus clustered insider activity. Tight liquidity and debt covenants increase the likelihood that insiders will use pre‑planned Rule 10b5‑1 programs for predictable sales or, conversely, opportunistic purchases to signal confidence when cash and margins stabilize. Regulatory risk tied to cannabis (federal illegality in the U.S.), product registrations (EPA/CFIA) and supplier concentration (>10% of purchases from one supplier) create recurring sources of material nonpublic information, so expect strict blackout periods around earnings and material disclosures and closely monitor Form 4 filings for transactions that precede or follow covenant or supply‑chain news.